CUSIP 02043Q107COMALNYQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
833 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Capital World Investors | 16.30M | $6.48B | −132.5K | Reduced |
| 2 | Fmr LLC | 15.90M | $6.32B | −865.5K | Reduced |
| 3 | Vanguard Group Inc | 13.55M | $5.39B | −11.5K | Reduced |
| 4 | Blackrock, Inc. | 10.40M | $4.14B |
| +497.3K |
| Added |
| 5 | Capital Research Global Investors | 6.78M | $2.70B | −443.1K | Reduced |
| 6 | Jpmorgan Chase & Co | 4.72M | $1.88B | +176.2K | Added |
| 7 | State Street Corp | 3.23M | $1.28B | +147.5K | Added |
| 8 | Geode Capital Management, LLC | 2.65M | $1.06B | +151.5K | Added |
| 9 | Baillie Gifford & Co | 2.60M | $1.03B | −188.4K | Reduced |
| 10 | Norges Bank | 2.25M | $895.82M | +220.1K | Added |
See every fund holding Alnylam Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders